Towards Shorter, Child-Friendly Regimens for Treatment of Tuberculosis Disease and Infection in Children.
Yuen CM, Sekadde MP, Kaiser B, Waning B, Graham SM
Tuberculosis (TB)Evaluating the impact of Xpert® MTB/RIF on mortality from TB: are we asking the right questions?
Chani K, Sekadde MP, Dlodlo RA, Graham SM.
Global Infectious Disease Threats Tuberculosis (TB)